GlassScriptPhysician profile
Arjun Kumar Chagarlamudi
NPI 1568699932
$3,912.30
in general payments reported to CMS, 2019-2025
30 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,290 · 2020: $276 · 2021: $675 · 2022: $200 · 2023: $452 · 2024: $639 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $601.01 | 2019-2022 | |
| Boston Scientific Corporation | $415.15 | 2019-2024 | Rotapro, Wolverine Coronary Cutting Balloon, Avvigo Guidance System |
| Medtronic, INC. | $389.86 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Abiomed | $333.05 | 2022-2025 | Impella |
| Penumbra, INC. | $247.89 | 2019-2024 | Indigo System, Penumbra System |
| Philips North America LLC | $240.41 | 2019-2024 | (9266) Elca |
| Abbott Laboratories | $179.64 | 2019-2025 | Diamondback Coronary, Xience Skypoint, Perclose Prostyle |
| Shockwave Medical, INC | $176.21 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.02 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $124.65 | 2019-2023 | Farxiga |
| Chiesi USA, INC. | $100.92 | 2019-2023 | Cleviprex, Kengreal |
| Change Healthcare Technologies, LLC | $95.08 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $92.70 | 2019 | |
| Amgen INC. | $90.48 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $77.06 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $74.60 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $70.37 | 2019-2021 | |
| Pfizer INC. | $68.95 | 2019-2021 | |
| Opsens INC. | $47.55 | 2019 | |
| Amarin Pharma, INC. | $47.21 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $46.34 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $46.22 | 2019-2021 | |
| Acist Medical Systems, INC. | $43.76 | 2024 | |
| Gilead Sciences, INC. | $31.77 | 2019 | |
| Cardiva Medical, INC. | $31.76 | 2021 | |
| Cook Medical LLC | $23.16 | 2025 | Zilver Ptx |
| Inari Medical, INC. | $19.04 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $13.69 | 2021 | |
| Cmp Pharma, INC. | $13.25 | 2021 | |
| Bardy Diagnostics, INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Chagarlamudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.